Fig. 3From: Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women Cost-effectiveness acceptability curve showing the probability that foetal RHD genotyping is cost-effective compared to usual care based on the uncertainty in cost and effect differences shown in Fig. 2Back to article page